Clinical Trial Update: ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

The clinical trial evaluating ALT-801-activated natural killer cells with FLAG induction for acute myeloid leukemia (NCT01478074) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ALT-801-activated Natural Killer Cells

Snippet

Sponsor: Altor BioScience | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: WITHDRAWN